Dr Lucy Hooper

Founder My Genetic Cancer Risk

GP and Co-Founder Coyne Medical Ltd

Wife, mother, sister, daughter.

 

Turning 40 got me worrying about my health, especially my risk of breast cancer. My grandmother had died from breast cancer in her 50's, but I was 'low risk'. I did not qualify for breast cancer genetic testing in the NHS.

I chose to have a Complete Genetic Health screen. I wanted to take every chance to protect my health for my children. I was diagnosed with a mutation in a breast cancer gene. My chance of getting breast cancer was around 60% in my lifetime, especially in my 40's.

I was incredibly fortunate all my screening tests were clear. I had a risk-reducing double mastectomy in September 2020. My risk of breast cancer is now less than 5%. I'm now less likely to get breast cancer than an average woman.

I believe all women should have the choice to have genetic testing. Knowledge truly is power.

After I got my results I spent a lot of time researching genetic testing for breast cancer risk. I thought that as I did not meet the NHS criteria for genetic testing I didn’t need to worry about it. This is wrong, over 50% of people with a mutation in a cancer susceptibility gene have NO family history of cancer. If we continue to follow the current guidelines it could take over 250 years to discover all BRCA gene carriers in the UK.

Why do I believe we need to increase access to genetic testing?

 
“To identify a woman as a carrier only after she develops cancer is a failure of cancer prevention”
— Dr. Mary-Claire King. Discoverer of the BRCA1 gene.
Over 97% of people with BRCA mutations have not yet been identified in the UK
— Manchanda, R. et al. Current detection rates and time-to-detection of all identifiable BRCA-carriers in the Greater London population. Journal of Medical Genetics 2018;55:538-545. https://jmg.bmj.com/content/55/8/538.info
Population based testing for BRCA mutations could prevent over 50,000 cases of breast cancer in the UK
— Manchanda, R. et al. Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems. Cancers 2020, 12(7), 1929.
 

Spread the power

There are lots of ways to help empower more people know how genetic testing can protect them. Follow me on social media. Share this website with a friend or family member or use it to have a conversation about testing. Use our information to discuss test options with your doctor. If you are a healthcare professional then perhaps you are inspired to hold an educational event. Drop me a line and let me know.

Contact Me

If you think that this website is helpful, I’ve missed any new information or there is another way you think I can contribute then I’d love to hear from you.